Cornercap Investment Counsel’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,161	Closed	-$241K	–	676
2024 Q1	$241K	Buy	5,161 +15	+0.3%	+$700	0.04%	544
2023 Q4	$246K	Buy	+5,146	New	+$246K	0.04%	505